Weimin has been working at AstraZeneca’s bioassay group for 6 years. She does bench work and also serves as the bioassay rep in the CMC team. The projects Weimin involved include therapeutic mAbs, and oncolytic virus, etc. Prior to joining AZ, she worked in the Translational Research Institute of The Scripps Research Institute in Florida. Her job there was compound screening and cell-based assay development for different kinase inhibitors. Weimin holds a M.Sc degree in Chemistry from Nanjing University, China.